High-sensitivity c-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Kawamoto, Ryuichi ^a,b   Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Kusunoki, Tomo ^a,b   Takayama, Shuzo ^a   Abe, Masanori ^a   Katoh, Tateaki ^b   Ohtsuka, Nobuyuki ^b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; RISK; RISK ASSESSMENT; RISK FACTOR; RURAL POPULATION; STATISTICAL MODEL; UPREGULATION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN RESISTANCE; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; RURAL POPULATION; UP-REGULATION;

EID: 78649765012     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-87     Document Type: Article

References (45)

1. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, . San Antonio Heart Study The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003, 26:3153-3159. 10.2337/diacare.26.11.3153, 14578254, San Antonio Heart Study.
2. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28:385-390. 10.2337/diacare.28.2.385, 15677797.
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716. 10.1001/jama.288.21.2709, 12460094.
4. Kekeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohata J, Isobe T, Fujiwara T, Akasaka K, Shimada K. Metabolic syndrome and insulin resistance in Japanese Male-Tanno-Soubetsu Study. J Japan Diab Soc 2003, 46:739-744. (in Japanese, Abstract in English).
5. Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yamasaki M, Kim JM, Kim IS, Lee SK, Oyunsuren T, Yamane Y. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 2005, 47:126-135. 10.1539/joh.47.126, 15824477.
6. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98:731-733.
7. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003, 168:351-358. 10.1016/S0021-9150(03)00134-5, 12801619.
8. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, Yamamoto Y, Yamashina A. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005, 45:997-1003. 10.1161/01.HYP.0000165018.63523.8a, 15837828.
9. Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 1980, 12:1-58. 10.3109/10408368009108725, 6104563.
10. Devries MC, Samjoo IA, Hamadeh MJ, Tarnopolsky MA. Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women. Obesity (Silver Spring) 2008, 16:2281-2288. 10.1038/oby.2008.358, 18719669.
11. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007, 27:127-133. 10.1161/01.ATV.0000251993.20372.40, 17095717.
12. Jimba S, Nakagami T, Oya J, Wasada T, Endo Y, Iwamoto Y. Increase in gamma-glutamyltransferase level and development of established cardiovascular risk factors and diabetes in Japanese adults. Metab Syndr Relat Disord 2009, 7:411-418. 10.1089/met.2008.0082, 19419267.
13. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003, 254:287-295. 10.1046/j.1365-2796.2003.01198.x, 12930239.
14. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007, 27:127-133. 10.1161/01.ATV.0000251993.20372.40, 17095717.
15. Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010, 13:36-41. 10.1111/j.1751-7141.2009.00054.x, 20021625.
16. Strasak AM, Kelleher CC, Klenk J, Brant LJ, Ruttmann E, Rapp K, Concin H, Diem G, Pfeiffer KP, Ulmer H. Vorarlberg Health Monitoring and Promotion Program Study Group. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol 2008, 28:1857-1865. 10.1161/ATVBAHA.108.170597, 2643843, 18617645.
17. Taki K, Nishio K, Hamajima N, Niwa T. Metabolic syndrome defined by new criteria in Japanese is associated with increased liver enzymes and C-reactive protein. Nagoya J Med Sci 2008, 70:1-9.
18. The Japanese Society of Nephrology Japanese version of GFR estimation. 2007, Updated Oct 29., The Japanese Society of Nephrology., http://www.jsn.or.jp
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
20. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, . American Heart Association; National Heart, Lung and Blood Institute Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958, American Heart Association; National Heart, Lung and Blood Institute.
21. The examination Committee of Criteria for "Obesity Disease" in Japan Japan Society for Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002, 66:987-992. 10.1253/circj.66.987, 12419927, The examination Committee of Criteria for "Obesity Disease" in Japan.
22. Ota T, Takamura T, Hirai N, Kobayashi K. Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diabetes Care 2002, 25:1252-1253. 10.2337/diacare.25.7.1252, 12087037.
23. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 2007, 49:1798-1805. 10.1016/j.jacc.2007.01.065, 17466231.
24. Okosun IS. Metabolic syndrome and C-reactive protein in American adults: the impact of abdominal obesity. Metab Syndr Relat Disord 2008, 6:289-297. 10.1089/met.2008.0040, 19067532.
25. Wen J, Liang Y, Wang F, Sun L, Guo Y, Duan X, Liu X, Tao Q, Wong TY, Lu X, Wang N. Association of C-reactive protein and metabolic syndrome in a rural Chinese population. Clin Biochem 2009, 42:976-983. 10.1016/j.clinbiochem.2009.03.026, 19358836.
26. Seet RC, Lee CY, Lim EC, Quek AM, Huang SH, Khoo CM, Halliwell B. Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. Diabetes Care 2010, 33:1140-1142. 10.2337/dc09-2124, 20185735.
27. Wen J, Liang Y, Wang F, Sun L, Guo Y, Duan X, Liu X, Tao Q, Wong TY, Lu X, Wang N. Association of C-reactive protein and metabolic syndrome in a rural Chinese population. Clin Biochem 2009, 42:976-983. 10.1016/j.clinbiochem.2009.03.026, 19358836.
28. Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyl transferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004, 27:1427-1432. 10.2337/diacare.27.6.1427, 15161799.
29. Steinvil A, Shapira I, Ben-Bassat OK, Cohen M, Vered Y, Berliner S, Rogowski O. The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol 2010, 9:30. 10.1186/1475-2840-9-30, 2915953, 20633271.
30. Kang YH, Min HK, Son SM, Kim IJ, Kim YK. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Res Clin Pract 2007, 77:306-313. 10.1016/j.diabres.2006.11.009, 17353063.
31. André P, Balkau B, Vol S, Charles MA, Eschwège E, . DESIR Study Group Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 2007, 30:2355-2361. DESIR Study Group.
32. Jo SK, Lee WY, Rhee EJ, Won JC, Jung CH, Park CY, Oh KW, Park SW, Kim SW. Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria. Clin Chim Acta 2009, 403:234-240. 10.1016/j.cca.2009.03.035, 19332046.
33. Ryu S, Chang Y, Woo HY, Yoo SH, Choi NK, Lee WY, Kim I, Song J. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men. Metabolism 2010, 59:683-689. 10.1016/j.metabol.2009.08.024, 19922966.
34. Kawamoto R, Kohara K, Tabara Y, Miki T, Otsuka N. Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. J Atheroscler Thromb 2009, 16:355-362.
35. Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 2003, 27(Suppl 3):S53-S55. 10.1038/sj.ijo.0802502, 14704746.
36. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006, 74:443-477. full_text, 17027526.
37. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-751.
38. Bo S, Gambino R, Durazzo M, Guidi S, Tiozzo E, Ghione F, Gentile L, Cassader M, Pagano GF. Associations between g-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: A possible implication for oxidative stress. World J Gastroenterol 2005, 11:7109-7117.
39. Lee DH, Jacobs DR. Association between serum gammaglutamyltransferase and C-reactive protein. Atherosclerosis 2005, 178:327-330. 10.1016/j.atherosclerosis.2004.08.027, 15694941.
40. Tabara Y, Osawa H, Kawamoto R, Tachibana-Iimori R, Yamamoto M, Nakura J, Miki T, Makino H, Kohara K. Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab 2008, 93:715-722. 10.1210/jc.2007-0397, 18160463.
41. Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?. Free Radic Biol Med 2004, 37:1018-1023. 10.1016/j.freeradbiomed.2004.06.032, 15336318.
42. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998, 25:786-792. 10.1016/S0891-5849(98)00127-0, 9823544.
43. Kawamoto R, Ohtsuka N, Ninomiya D, Nakamura S. Carotid atherosclerosis in normal-weight metabolic syndrome. Intern Med 2007, 46:1771-1777. 10.2169/internalmedicine.46.0261, 17978533.
44. Oda E, Kawai R. Reproducibility of high-sensitivity C-reactive protein as an inflammatory component of metabolic syndrome in Japanese. Circ J 2010, 74:1488-1493. 10.1253/circj.CJ-10-0156, 20519874.
45. Farah R, Shurtz-Swirski R, Lapin O. Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment. Cardiovasc Diabetol 2008, 7:20. 10.1186/1475-2840-7-20, 2441608, 18570678.